All Articles

Friedman Industries just announced its 218th straight quarterly dividend, a rare feat. But what does this signal of reliability mean amid industry shifts and questions about its cash flow?

In a bold strategic shift, Identiv sells its core IoT business to Trackonomy, transforming into a SaaS firm powered by a major stake in the AI leader.

A class-action lawsuit claims First Solar misled investors about its ability to handle U.S. tariffs, leading to stock drops and analyst downgrades.

A new ARPA-H grant aims to replace 50-year-old tech with a rapid blood test for fetal hypoxia, a move that could slash C-sections and save lives.

After a Q1 revenue miss, all eyes are on ICF's upcoming Q2 results. Can its booming commercial energy sector offset federal headwinds and validate its ambitious 2026 guidance?

Work World appoints a new CFO to steer its PE-backed expansion. We dive into the strategy of acquisitions, tech upgrades, and market consolidation.

A new ranking from CNBC spotlights a major industry shift. It’s no longer just about assets; it’s about integrated, tech-enabled fiduciary care.

The FDA has approved TRYNGOLZA, the first drug to reduce triglycerides and acute pancreatitis risk, marking a new era for millions and a pivotal moment for Ionis.

OpenVC's new Unicorn Fund isn't just another fund; it's a systematic attempt to map and monetize the private market frontier where real value now grows.

As the cannabis industry grapples with billions in unpaid invoices, Reklaim Credit Solutions is betting on deep expertise to build the credit system it desperately needs.

Beyond oil, Saudi Arabia is serving a new narrative at Taste of London. Is this culinary diplomacy a recipe for redefining a nation on the world stage?

Champion Petfoods' new Alberta innovation hub promises a scientific leap for pet food, but what does this Mars-backed investment mean for science and the state?

With renewed funding for aiEDU, Google.org is betting on a teacher-led model for AI readiness. But can it overcome systemic inequities and educator apprehension?

A small biotech reports its novel curcumin gel eases sickle cell pain. But its strategy of pre-approval access via pharmacies is a high-stakes economic gamble.

With a key hire from Apple, a startup aims to move pet care beyond gadgets by building a clinically-backed AI system. But can it earn the trust of vets and owners?

GCL SI pivots to back-contact tech with its GPC 3.0 module, blending high efficiency, sleek aesthetics, and low-carbon manufacturing for Europe.

Hyperscale Data touts a massive power expansion for AI and crypto in Montana. But behind the headline is a decade-long gauntlet of financial and logistical hurdles.

The convenience giant's new 3-year plan bets on AI-driven efficiency and digital tools to expand its food empire and deliver on ambitious growth targets.